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Smnmarn We studied the association between deprivation and survival from breast cancer in 29 676 women
aged 30 and over who were diagnosed during the period 1980-89 in the area covered by the South Thames
Regional Health Authority. The measure of deprivation was the Carstairs Index of the census enumeration
distnrct of each woman's residence at diagnosis. We studied the impact of stage at diagnosis, morphology and
type of treatment on this association, with the relative survival rate and the hazard ratio as measures of
outcome. There was a clear gradient in survival. with better survival for women from more affluent areas. At
all ages. women in the most deprived category had a 35% greater hazard of death than women from the most
affluent areas after adjustment for stage at diagnosis, morphological type and type of treatment. In younger
women (30-64 years). the survival gradient by deprivation category cannot be explained by these prognostic
factors. In older women (65-99 years). part of the unadjusted gradient in survival can be explained by
differences in the stage of disease: older women in the most deprived category were more often diagnosed with
advanced disease. Other factors. so far unidentified, are responsible for the gradient in breast cancer survival
by deprivation category. The potential effect on breast cancer mortality of eliminating the gradient in survival
by deprivation category is substantial (7.4%). In women aged 30-64 years, 10% of all deaths within 5 years
might be avoidable. while in older women this figure is 5.8%.
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A 25% reduction in breast cancer mortality by the year 2000
among women invited for screening was set as a target for
the Health of the Nation strategy in England (Department of
Health, 1992). This reduction is unlikely to be reached by a
reduction in the incidence of breast cancer, because incidence
at ages 45-74 is still rising (Coleman et al., 1993) and the
major risk factors so far identified for breast cancer, such as
nulliparity, late age at first birth and late age at menopause
(Kelsey et al.. 1993), are not amenable to intervention. Im-
provement in survival is a more promising approach to the
reduction of breast cancer mortality: this is the focus of the
National Breast Screening Programme (Chamberlain et al.,
1993a). Considerations of equity would require different
socioeconomic groups of patients to have equal chances of
survival from breast cancer (Expert Advisory Group on
Cancer. 1994). It is therefore important to monitor any
socioeconomic variation in breast cancer survival and if pos-
sible to determine its causes.
Socioeconomic variation in breast cancer survival has been
reported from Finland, Sweden, England and Wales, Scot-
land, the USA and Australia, using either individual (VAger6
and Persson. 1987; Karjalainen and Pukkala, 1990;
Kogevinas et al.. 1991) or area-based measures (Dayal et al.,
1982: Bonett et al.. 1984; Bassett and Krieger, 1986; Anssell
et al., 1993: Carnon et al.. 1994) of socioeconomic status.
These studies have shown that breast cancer patients from
higher socioeconomic groups have higher survival rates,
except for the English study, which found a weak reverse
gradient (Kogevinas et al.. 1991).
We studied variation in breast cancer survival between
categories of deprivation in the area covered by the South
Thames Regional Health Authority (RHA). which includes
London south of the River Thames and the counties of Kent.
Surrey and Sussex. with a population around 6.5 million. We
examined the influence of several prognostic factors on this
variation, and evaluated the potential effect on mortality of
eliminating any gradient in survival by category of depriva-
tion.
Patients and methods
Data source andpatients
Data for this study came from the Thames Cancer Registry,
a population-based cancer registry covering a population of
14.1 million people in south-east England. The Registry has
been operating continuously since 1960, covering the territory
of what is now South Thames RHA until 1984. Coverage
was extended to the territory of North Thames RHA in
1985, but because we analysed survival for women diagnosed
from 1980, only women resident in South Thames RHA were
included. The methods and data quality indices of the Regis-
try have been described (Skeet. 1991; Thames Cancer Regis-
try, 1994) and incidence for the 1980s reported (Skeet et al.,
1987; Thames Cancer Registry. 1992a,b; Chamberlain et alt,
1993b).
All 35000 female residents of South Thames RHA who
were diagnosed with a malignant breast tumour in the decade
1980-89 were eligible for study. The mean age at diagnosis
was 63 years (range 30-99 years). The 2822 (8.1%) women
for whom the date of death was known but the date of
diagnosis unknown (death certificate only cases, DCO). were
excluded from analysis because their survival time could not
be calculated. A further 2502 (7.1%) cases with an incom-
plete or unknown postcode were also excluded, since their
census enumeration district could not be reliably determined
(see below). A total of 29 676 women (84.8% of those eligi-
ble) were included in survival analyses. No distinction was
made between cases for which histological evidence of malig-
nancy was (77.3%) or was not available to the Registry,
because this percentage did not differ systematically between
depnrvation categones.
Deprivation score
The measure of deprivation for each woman was based on
her usual residence at diagnosis. by linking the full postcode
of residence to the corresponding census enumeration district
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data from the 1981 census were obtained on four variables:
overcrowding (proportion of persons in private households
living at a density of more than one person per room as a
proportion of all persons in private households). male
unemployment (proportion of economically active males who
are seeking work), low social class (proportion of all persons
in private households with head of household in social class 4
or 5) and car ownership (proportion of all persons in private
households with no car).
The Carstairs Index combines these four variables for a
given small geographic area into a single score, considered to
represent material deprivation (Carstairs and Morris, 1991).
The value of each variable for each ED is first standardised
by subtracting the mean value for Great Britain as a whole.
and dividing the result by the population standard deviation.
The sum of the four standardised scores for each ED pro-
vides its Carstairs Index.
Each ED in South Thames was then assigned to one of
five deprivation categories. constructed by ranking the Car-
stairs scores for all EDs in Great Britain from low ('affluent')
to high ('deprived') and dividing this distribution into quin-
tiles.
Prognosticfactors
Age was initially studied in three categories. 30-49. 50-64
and 65-99 years. but survival patterns across deprivation
categories were very similar for the two youngest age groups,
and they were combined for analysis. Period ofdiagnosis was
studied in two quinquennia. 1980-84 and 1985-89. since
overall survival from breast cancer was higher in the later
period. Stage at diagnosis (clinical or pathological) was ex-
plicitly stated in the medical records for fewer than 20% of
breast cancer patients (Chouillet et al.. 1994). A simplified
stage is routinely constructed by Registry staff for all cases.
however, using pathology reports. operation notes and other
information: it is available for some 80% of cases. Stage was
categorised in three groups for this study: local (tumour
confined to the breast). regional (involvement of lymph
nodes) and metastasis (spread to other organs). Patients for
whom the stage at diagnosis was unknown were included in
the analysis as a fourth category. Morphology was studied in
three categories: ductal. other specific morphology and un-
known morphology. Finally. type of treatment was studied in
seven broad categories: surgery; surgery plus radiotherapy;
surgery plus chemotherapy; surgery plus radiotherapy plus
chemotherapy; radiotherapy plus chemotherapy: no treat-
ment; and treatment unknown.
Survival analisis
The survival time in years for each woman was calculated as
the number of days between the date of diagnosis and the
date of death or 31 December 1992 (whichever occurred first)
divided by 365.25. Potential follow-up time ranged from 3 to
13 years.
To adjust for mortality from causes other than breast
cancer, we used the relative survival rate as measure of
outcome in the univariate analyses. The relative survival rate,
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expressed as a percentage (RSR%). is the ratio of the sur-
vival observed in the group of cancer patients and the sur-
vival that would be expected if they were subject to the same
overall mortality rates by age and calendar period as the
general population (Cutler and Ederer. 1958). Expected sur-
vival was computed from the England and Wales life table
for 1981. The computer programme from the Finnish Cancer
Registry was used to calculate the RSR and its 9500
confidence interval (CI) (Hakulinen and Abeywickrama.
1985). Multivariate analysis was conducted with a propor-
tional hazards model adpated to the RSR (Hakulinen and
Tenkanen. 1987) using GLIM (Payne. 1985). The measure of
outcome was the hazard ratio. which expresses the pro-
bability of death for a specific category of patients relative to
a referent category with probability of death defined as unity.
The basic model included the duration of follow-up (up to
5 and 6-13 years) and deprivation category: prognostic fac-
tors were added as categorical variables in a fixed order; first.
period of diagnosis. then factors considered to be inter-
mediate in any association between deprivation and survival.
namely stage at diagnosis. morphology and type of treat-
ment. The improvement in fit of the model obtained from
each additional prognostic factor was tested for statistical
significance at the 5% level using the chi-square distribution
for the reduction in deviance from the preceding model with
the corresponding difference in degrees of freedom. The
statistical significance of the trend in the hazard ratio across
depnrvation categories was tested by examining the effect of
adding deprivation category to the model as a continuous
variable.
Mortality reduction
We estimated the reduction in mortality 5 years after breast
cancer diagnosis which might be achieved if any socio-
economic gradient in survival were eliminated. In order to
obtain the number of deaths that would have been expected
if all women had experienced the survival of the most affluent
group. cumulative (crude) death rates at 5 years were cal-
culated for each 5 year age group in the most affluent patient
category and applied to the numbers of women in the corres-
ponding age group in the other deprivation categories. The
potential reduction in mortality was calculated for the age
groups 30-64 and 65-99 and for each deprivation category.
as both the absolute and the percentage difference between
observed and expected deaths. A similar calculation was
done for the age group 50-69 years. which will be monitored
for breast cancer mortality in relation to the national Breast
Screening Programme (Department of Health. 1993).
Results
A third (34%) of the women with breast cancer lived in the
32.9% of areas categorised to the most affluent quintile of
the Carstairs Index. while only 6% lived in the 8.9% of areas
categorised as the most deprived (Table I). These distribu-
tions reflect both the relative affluence of South Thames
within Great Britain and the higher incidence of breast
cancer in more affluent women.
Table I Breast cancer. South Thames. 1980-89: number (%0) of enumeration districts
(EDs). number (0o) ofcases and relative survival rates (RSR%) at 5 and 10vears. with95%o
confidence intervals (95% CI). by deprivation category
Deprivation Number (%0) of Number (%0) of Five -iear RSR Ten year RSR
category EDs cases (95% CI} (95% CI)
Affluent 4739 (32.9) 10097 (34.0) 71 (69-73) 59 (57-61)
(2) 3251 (22.6) 7147 (24.1) 67 (65-69) 54(52-56)
(3) 2763 (19.2) 6107 (20.6) 63 (62-64) 51 (49-53)
(4) 2359 (16.4) 4536 (15.3) 64 (62-66) 50 (47-53)
Depnrved 1274 (8.9) 1789 (6.0) 60 (57-63) 48 (44-52)
Total 14 386 (100) 29 676 (100) 67 (66-68) 54 (53-55)d- _ J s l
CTM Sdvers eta
740
TaMe H Breast cancer, SouthTbams, 1980-89 5 yearrelative survival (RSR%), 95%
confidence interval (CI) and number ofcases, by deprivation category and age group
Depriation category
Age group Affunt (2) (3) (4) Deprived Total
30-64 years
Five year RSR% 73 70 66 65 64 69
95% CA 71-75 68-72 64-68 63-67 61-67 68-70
No. ofcases 5609 3495 2912 2234 910 15 160
65-99 years
Five year RSR% 67 63 60 62 53 63
95% Cl 65-69 61-65 58-62 59-65 49-57 62-64
No. of cases 4488 3652 3195 2302 879 14 516
r-
'I
>
=
a
!59-
1 2 3 4 5 6 7
Years since diagnosis
Fwe 1 Breast cancer, South Tbames, 1980-89. Relative sur-
vival (%) in women from the most affluent (A) and most dep-
rived (0) enumeration districts, by time since diagis. *See
Table I.
Survival at both 5 and 10 years was higher in the more
affluent patient groups. The difference in survival between the
most affluent and most deprived category increased slightly
with time since diagnosis (Figure 1). The absolute difference
in survival between these two groups was more than 10%,
and the survival gradient across deprivation categories was
clear, although women in the third and fourth categones had
similar survival rates.
The survival gradient across deprivation categories was
steeper for older women than for younger women (Table I).
The distribution of prognostic factors by deprivation
category was therefore studied separately for these two age
groups; an example is shown in Table m for stage at diag-
nosis. For women aged 30-64 years, there was no consitent
pattern in stage by deprivation category. Among women
aged 65-99 years, the distribution of stage at diagnosis was
more adrvanced in the most deprived group, of whom 17%
presented with metastases.
Differences in stage distribution by age and deprivation
category were generally small, however, and the patterns of
survival by stage were very similar for the age groups 30-64
and 65-99 years. Stage-specific survival rates are therefore
presented in Table IV for all ages combined. In every
category of stage, survival at 5 years was higher for women
from more affluent areas, with a clear gradient. Multivariate
analysis was conducted separately for the two age groups
(Table V). Within these broad age categories, analysis of
finer subdivisions of age did not alter the relationship
Table m Bat cancer, SouthThanes, 1980-89: stage atdiagnosis
(%) by age group and deprivation category
Deprivion category
Stage Afflaent (2) (3) (4) Deprwed Total
30-64 yeArs
Loxca 47.8 48.0 50.5 48.6 48.3 48.5
Regional 23.1 25.4 24.6 25.1 27.7 24.5
Metastasis 7.5 8.0 7.7 9.0 7.5 7.9
Unknown 21.6 18.7 17.2 17.3 16.6 19.1
100.0 100.0 100.0 100.0 100.0 100.0
65-99 years
local 49.2 49.7 51.1 47.6 41.3 49.0
Regional 18.2 18.3 17.8 18.5 18.5 18.2
Metastasis 9.9 10.7 11.0 12.0 17.3 11.1
Unknown 22.7 21.3 20.1 21.9 22.9 21.7
100.0 100.0 100.0 100.0 100.0 100.0
between deprivation and survival. For women aged 30-64
years, there was a clear gradient in the probability of death
across deprivation categores, with higher hazard ratios for
the more deprived groups (model 1). Addition of period of
diagnosis did not change the hazard ratios (model 2). Adjust-
ment for stage at diagosis altered the hazard ratios for
individual depnvation categories only slightly (model 3),
while neither morphology nor type of treatment had any
substantial influence on the hazard ratios (models 4 and 5).
In the final model, including duration offollow-up, period of
diagnosis, stage, morphology and type of treatment, the
gradient in survival across deprivation categories was still
apparent, with a 36% excess hazard of death in the most
deprived category.
For women aged 65 years and over, the gradient of hazard
ratio by deprivation category was more marked, especially
for the most deprived category (hazard ratio 1.69; model 1).
Adjustment for stage at diagnosis reduced the gradient
(model 3), while adjustment for morphology (model 4) had
little effect. Adjusting for the type of treatment (model 5)
mainly reduced the hazrd in the most deprived group; in
this model, inclding the same variables as for younger
women, the socioeconomic gradient in survival was also still
apparent, with a similar 34% excess hazard of death in the
most deprived category.
For both age groups and in each model, addition of each
prognostic factor signicantly improved the fit over that of
the preceding model, and the trend in hazard ratio across
deprivation categories was statistically significnt (two-sided
P-value<0.00001 in each case). Finer subdivision of period
of diagnosis and follow-up time did not alter the results in
either of the age groups.
Of the 12 911 deaths that occurred within 5 years of breast
cancer diagosis, 960 (7.4%) might have been avoided if all
women had experienced the survival of the most affluent
category (Table VI). There was a higher percentage of poten-
tially avoidable deaths in the more depnved categoris: 6.5%,12.3%, 11.8% and 17.8% in categories 2-5, respectively. The
potential reduction in mortality was larger in women aged
30-64 years (506 deaths, 10% of all deaths) than in women
aged 65-99 years (454 deaths, 5.8%). Finally, in the age
group 50-69 years, the overall potential reduction in mor-
tality at 5 years was just over 10% (507) of all deaths,
reaching 22% (74 deaths) in the most deprived category.
Dep6mi nd ub so! co-co wv*
CTM Schdsver etal
741
Our results show a gradient in survival for women diagnosed
with breast cancer in the South Thames region between 1980
and 1989 according to a measure of material deprivation in
the small area of their residence at diagnosis. Survival among
women from deprived areas was lower than for women from
Table IV Breast cancer, South Thames, 1980-89: 5 year relative survival (RSR%). 95%
confidence interval (CI) and number of cases, by deprivation category and stage at
diagnosis
Stage
Local RSR%
95%CI
No. of cases
Regional RSR%
95%CI
No. of cases
Metastasis RSR%
95%CI
No. of cases
Unknown RSR%
95%CI
No. of cases
Total RSR%
95%CI
No. of cases
Affluent
84
83-85
4892
64
61 -67
2111
26
22-30
865
65
63-67
2229
71
69-73
10097
Deprivation category
(2) (3) (4)
82 78 80
80-84 76-80 78-82
3488 3103 2181
61
58-64
1555
23
19-27
671
57
53-61
1433
67
65-69
7147
58
55-61
1285
21
17-25
578
50
46-54
1141
63
62-64
6107
57
53-61
986
23
18-28
477
52
48-56
892
64
62-66
4536
TableV Breast cancer, South Thames, 1980-89: hazard ratios and 95% confidence intervals (CI) by
age and deprivation category; adjustment for prognostic factors
30-64 years
Deprivation Hazard Difference' in: Ha
category ratio (95% CI) deviance df. rz
Model 1: Deprivation,follow-up period (1-5 and 6-13 years)
Affluent 1.00 259 5 1
(2) 1.15 1.05-1.27 1
(3) 1.30 1.18-1.43 1
(4) 1.31 1.18-1.46 1
Deprived 1.35 1.17- 1.57 1
65-99 years
=zard Difference' in:
atio (95% CI) deviance d.f.
.00
17
L.24
.23
.69
1.02-1.33
1.08-1.42
1.06-1.43
1.41-2.03
295 5
Model 2: Deprivation,follow-up period andperiod ofdiagnosis (1980-84 and 1985-89)
Affluent 1.00 5 1 1.00 I
(2) 1.15 1.05-1.27 1.16 1.02-1.33
(3) 1.30 1.18-1.44 1.24 1.09-1.42
(4) 1.31 1.18-1.46 1.23 1.06-1.43
Deprived 1.35 1.16-1.57 1.68 1.39-2.03
Model 3: Deprivation,follow-up period, period ofdiagnosis and stage at diagnosis
Affluent 1.00 1874 3 1.00 1995 3
(2) 1.16 1.06-1.26 1.15 1.02-1.29
(3) 1.34 1.23-1.46 1.23 1.09-1.38
(4) 1.30 1.18- 1.43 1.16 1.01-1.32
Deprived 1.39 1.22-1.59 1.47 1.25- 1.74
Model 4: Deprivation,follow-up period, period ofdiagnosis, stage at diagnosis and morphology
Affluent 1.00 83 2 1.00 101
(2) 1.16 1.07-1.27 1.15 1.03-1.29
(3) 1.35 1.24- 1.48 1.23 1.09- 1.38
(4) 1.31 1.19-1.43 1.18 1.03-1.34
Deprived 1.41 1.24- 1.61 1.46 1.24- 1.72
2
Mode15:Deprivation,follow-upperiod,periodofdiagnosis,stageatdiagnosis,morphology andtreatment
Affluent 1.00 1071 6 1.00 1073 6
(2) 1.12 1.03-1.21 1.17 1.06-1.28
(3) 1.32 1.22-1.44 1.23 1.11-1.35
(4) 1.30 1.19-1.42 1.16 1.04-1.29
Deprived 1.36 1.21-1.54 1.34 1.17-1.54
'Differencefrom preceding model. Formodel 1,difference frommodelincludingonlyconstant term;
5 d.f. refers to 4 d.f. for deprivation and 1 d.f. for follow-up period.
Deprived
77
73-81
802
56
51 -61
415
16
10-22
220
49
43-55
352
60
57-63
1789
Total
81
80-82
14 466
60
56-64
6352
23
21 -25
2811
57
56-58
6047
67
66-68
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Table VI Breast cancer. South Thames. 1980 -89: observed. expecteda
and asoidable' deaths at 5 years. bv age and depnrvation category
Deprivation No. ofdeaths Avoidable deaths
category Age group Observed Expected % No.
Affluent 30-64 1674 1674 - -
65-99 2282 2282 - -
Total 3956 3956 - -
.50-69 1486 1486 - -
(2) 30-64 1150 1058 8.0 92
65-99 1965 1854 5.6 111
Total 3115 2912 6.5 203
50-69 1154 1049 9.1 105
(3) 30-64 1070 884 17.4 186
65-99 1783 1617 9.3 166
Total 2853 2501 12.3 352
50 -69 1076 896 16.7 180
(4) 30-64 836 678 18.9 158
65-99 1263 1174 7.0 89
Total 2099 1852 11.8 247
50-69 831 683 17.8 148
Depnrved 30-64 345 275 20.3 70
65-99 543 455 16.2 88
Total 888 730 17.8 158
50-69 333 259 2.2 74
Total 30-64 5075 4569 10.0 506
65-99 7836 7382 5.8 454
Total 12911 11 951 7.4 960
50-69 4880 4373 10.4 507
aFrom elimination ofsurvival gradient acrossdepnrvationcategories.
bDifference between observed and expected deaths (see text).
affluent areas during the entire 13 year follow-up period and
at all ages, but the gradient in survival across deprivation
categories was steeper for older women (65-99 years). The
hazard ratio for the most deprived category was 1.35 for
younger women and 1.69 for older women, but after adjust-
ment for calendar period of diagnosis, stage at diagnosis,
morphology and type of treatment, the excess hazard was
still about 35% for both age groups.
Four methodological issues affect the interpretation of
these results. First. the area-based measure of deprivation
used here (Carstairs Index) is a proxy measure for the dep-
rivation of individual breast cancer patients at the time of
diagnosis, and therefore the gradient in survival by depriva-
tion might be underestimated. However, this measure has
been shown to have a stronger association with mortality
than social class based on occupation, while there are many
problems with measuring social class based on occupation,
especially for women (Carstairs and Morris, 1989). We used
information from the 1981 census to assign a deprivation
score to women diagnosed between 1980 and 1989. This
could have resulted in misclassification if the socioeconomic
characteristics of some enumeration districts changed sub-
stantially between 1981 and the time of breast cancer diag-
nosis for residents of such districts. Such changes cannot be
ruled out, but are unlikely to have occurred differentially
according to deprivation category, and would be expected to
cause underestimation of any differences in breast cancer
survival by deprivation category.
A second potential bias arises from the use of national
rather than regional life tables to adjust for expected mor-
tality. All-cause mortality was higher in England and Wales
as a whole than in South Thames (OPCS, 1987), so expected
survival will be lower (and relative survival higher) than if
regional life tables had been used. It seems unlikely, however,
that differences between the various deprivation categories in
life expectancy calculated nationally or regionally would be
so great as to produce substantial bias in the relative survival
gradient for breast cancer. Similarly, use of a single life table
for all women may also be criticised, since all-cause mortality
varies with social class: this might exaggerate any underlying
gradient in relative survival from breast cancer. Separate life
tables for social classes or deprivation categories are
unavailable however. There is some evidence that the
gradient in relative survival from breast cancer is robust to
differences between socioeconomic groups in mortality from
other causes. The ratio of breast cancer survival in Finland
between the highest and lowest social classes was 1.10 with
corrected survival rates (censoring deaths from other causes)
and 1.12 with relative survival rates (Karjalainen and Puk-
kala, 1990).
A third methodological issue concerns the exclusion from
analysis of DCO cases, for which survival time is unknown.
In this study the percentage of such cases was similar
(8-9%) in all deprivation categories. We were able to
estimate the effect of excluding DCO cases on observed
survival (J Bullard, in preparation). As a ratio of the
observed (unadjusted) survival at 5 years in the most affluent
group, observed survival at 5 years in groups 2-5 was
respectively 0.92, 0.87, 0.88 and 0.82. These ratios became
0.91, 0.86, 0.86 and 0.81 after correction for the exclusion of
DCO cases, and their exclusion could thus have had very
little effect on the gradient in survival reported here.
Fourth, the stage at diagnosis used in these analyses is not
identical to the TNM stage. The key advantages are that,
unlike TNM stage, it is available for most cases; it is simple;
it has been assigned by Registry staff with a standard
definition over many years; and. for cases for which both
stage codes are available, it has almost identical prognostic
significance (J-M Lutz, in preparation). It has been argued
that the most important explanatory factor for socio-
economic variation in breast cancer survival is a difference in
the stage distribution between deprivation categories, and in
some studies deprived women have been shown to present at
a more advanced stage than affluent women (Farley and
Flannery, 1989; Karjalainen and Pukkala, 1990; Wells and
Horm, 1992). No such pattern was observed in Scotland
(Carnon et al., 1994), or for younger women in this study.
For older women, differences in the stage distribution did
explain part of the variation in survival, the hazard ratio for
the most deprived group falling from 1.68 to 1.47 after
adjustment for stage.
Our results are similar to those from other studies in which
survival differences between socioeconomic groups persisted
after correction for the data available on stage at diagnosis
(Dayal et al., 1982; Bassett and Krieger. 1986; Karjalainen
and Pukkala, 1990). Part of the gradient in survival by
deprivation could be due to residual confounding by stage. If
women from deprived areas were diagnosed less accurately
than women from affluent areas, they would be understaged
more often, leading to greater misclassification of stage at
diagnosis in women from deprived areas. This assumption
could not be tested with cancer registry data however.
Our findings suggest that special attention to early detec-
tion and rapid referral of breast cancer should be given to
women aged 65 or more living in deprived areas. A strength
of area-based analyses is that such women could be identified
through their area of residence, perhaps for special health
education programmes. The other prognostic factors that we
studied had little impact (type of treatment) or no impact
(morphology) on the gradient in survival by deprivation
category.
We conclude that a gradient in breast cancer survival
according to deprivation still existed after adjustment for
stage at diagnosis, morphology and broad category of treat-
ment. Other factors might be responsible for the observed
gradient in breast cancer survival by deprivation category,
such as a poorer host resistance among the deprived patients,
which could be related to more co-morbidity, an adverse
nutritional status, less social support and negative psycho-
logical factors, such as a lesser ability to cope with a cancer
diagnosis. Aspects of the health care system which might beD ivai and breast cancer suvia
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related to the lower survival of the lower socioeconomic
groups are, apart from the type of treatment, adverse hos-
pital referral patterns, the lower quality or appropriateness of
treatment and worse compliance with treatment in these
groups of patients. For most of these factors. however, in-
formation is not available from cancer registry records, and
other approaches will be required to study their impact.
Preliminary results from a study in our territory of breast
cancer patients aged less than 50 suggest that survival was
significantly affected by the use of adjuvant therapy (Wolfe et
al., 1993). Hospital referral patterns are being examined.
The Health of the Nation target for breast cancer
envisages a 25% reduction in breast cancer mortality among
women aged 50-69 by the year 2000. Improving the survival
of breast cancer patients living in less affluent areas would
make a substantial contribution to this target. In women
aged 50-69 years the overall reduction would have been over
10% 5 years after diagnosis. Our results suggest that one way
of achieving this improvement would be to focus on
socioeconomic differences in stage at presentation in older
women. In younger women, other factors, so far unidentified,
are responsible for the socioeconomic gradient in breast
cancer survival.
Acknowledgements
CTM Schrijvers was supported by a grant from the Research and
Development programme of South West Thames Regional Health
Authority.
References
ANSELL D. WHITMAN S. LIPTON R AND COOPER R. (1993). Race,
income. and survival from breast cancer at two public hospitals.
Cancer. 72, 2974-2978.
BASSETT MT AND KRIEGER N. (1986). Social class and black-white
differences in breast cancer survival. Am. J. Public Health, 76,
1400-1403.
BONETT A. RODER D ANND ESTERMAN A. (1984). Determinants of
case survival for cancers of the lung, colon, breast and cervix in
South Australia. Mfed. J. Aust.. 141, 705-709.
CARNON AG. SSEMWOGERERE A. LAMONT DW. HOLE DJ. MAL-
LON EA. GEORGE WD AND GILLIS CR. (1994). Relation between
socioeconomic deprivation and pathological prognostic factors in
women with breast cancer. Br. .Med. J., 309, 1054-1057.
CARSTAIRS V AND MORRIS R. (1989). Deprivation and mortality:
an alternative to social class? Comm. .Mfed.. 11, 210-219.
CARSTAIRS V ANTD MORRIS R. (1991). Deprivation and health in
Scotland. Aberdeen University Press: Aberdeen.
CHAMBERLAIN J. MOSS SM. KIRKPATRICK AE. MICHELL M ANTD
JOHNS L. (1993a). National Health Service breast screening prog-
ramme results for 1991-2. Br. Med. J., 307, 353-356.
CHAMBERLAIN J. BOURNE HM AND THORNTON-JONES H.
(1993b)I UK, England. South Thames Region. 1983-87. In
Cancer Incidence in Five Continents. Vol. VI. IARC Scientific
Publications NO. 120. Parkin DM. Muir CS. Whelan SL. Gao
Y-T. Ferlay J. Powell J. (eds) pp. 790-793. IARC: Lyon.
CHOUILLET AM. BELL CMJ AND HISCOX JG. (1994). Management
of breast cancer in south-east England. Br. MUed. J.. 308,
168-171.
COLEMAN MP. ESTEVE J. DAMIECKI P. ARSLAN A AND RENARD
H. (1993). Trends in Cancer Incidence and .lortalitv . IARC
Scientific Publications No. 121. IARC: Lyon.
CUJTLER SJ AND EDERER F. (1958). Maximum utilisation of the life
table method in analyzing survival. J. Chronic Dis.. 8, 699-712.
DAYAL HH. POWER RN AND CHIU C. (1982). Race and socio-
economic status in survival from breast cancer. J. Chronic Dis.,
35, 675-683.
DEPARTMENT OF HEALTH. (1992). The Health of the Nation: a
Strategy for Health in England. HMSO: London.
DEPARTMENT OF HEALTH. (1993). The Health of the NVation:
Specification of National Indicators. HMSO: London.
EXPERT ADVISORY GROUP ON CANCER TO THE CHIEF MEDICAL
OFFICERS OF ENGLAND AND WALES. (1994). Consultative
Document: A Policy Framework for Commissioning Cancer Ser-
vices. Department of Health: London.
FARLEY TA AND FLANNERY JT. (1989). Late-stage diagnosis of
breast cancer in women of lower socioeconomic status: public
health implications. Am. J. Public Health. 79, 1508-1512.
HAKULIN-FN T AND ABEY'WICKRAMA KH. (1985). A computer
program package for relative survival analysis. Comp. Prog.
Biomed.. 19, 197-207.
HAKULINEN T AND TENKANEN L. (1987). Regression analysis of
relative survival rates. Appl. Stat.. 36, 309-317.
KARJALAINEN S AND PUKKALA E. (1990). Social class as a prog-
nostic factor in breast cancer surVival. Cancer. 66, 819-826.
KELSEY JL. GAMMON MD AN-D JOHN EM. (1993). Reproductive
factors and breast cancer. Epidemiol. Rev.. 15, 36-47.
KOGEVINAS M. MARMOT MG. FOX AJ AND GOLDBLATT PO.
(1991). Socioeconomic differences in cancer survival. J. Epidemiol.
Commun. Health. 45, 216-219.
OPCS. (1987). Mortalitv Statistics: Area, 1985. Series DH5 no. 12.
HMSO: London.
PAYNE CD. (1985). The GLI.U system release 3.77. Generalized
Linear Interactive .Uodelling Afanual. Numerical Algonrthms
Group: Oxford.
SKEET RG. (1991). The Thames Cancer Registr. In Cancer Registra-
tion: Principles and Methods, [ARC Scientific Publications No.
95. Jensen OM. Parkin DM. MacLennan R. Muir CS. Skeet RG.
(eds). pp. 237-245. IARC: Lyon.
SKEET RG. THORNTON-JONES H AND MURRELLS TJ. (1987). UK.
England. South Thames Region. 1978-1982. In Cancer Incidence
in Five Continents. Vol. V. IARC Scientific Publications No. 88.
Muir CS. Waterhouse JAH. Mack T. Powell J. Whelan SL (eds)
pp. 664-667. IARC: Lyon.
THAMES CANCER REGISTRY. (1992a). Cancer in South East
Thames, 1987-1989: Cancer Incidence, Prevalence and Survival in
Residents of the District Health Authorities in South East Thanes.
Thames Cancer Registry: Sutton.
THAMES CANCER REGISTRY. (1992b). Cancer in South West
Thames 1987-1989: Cancer Incidence, Prevalence and Survival in
Residents ofthe District Health Authorities in South West Thames.
Thames Cancer Registry: Sutton.
THAMES CANCER REGISTRY. (1994). Cancer in South East England
1991: Cancer Incidence, Prevalence and Survival in Residents of
the District Health Authorities in South East England. Thames
Cancer Registry: Sutton.
VAGERO D AND PERSSON G. (1987). Cancer survival and social
class in Sweden. J. Epidemiol. Commun. Health. 41, 204-209.
WELLS BL AND HORM JW. (1992). Stage at diagnosis in breast
cancer race and socioeconomic factors. Am. J. Public Health. 82,
1383-1385.
WOLFE CDA. BARTON J. BOURNE HM AND RICHARDS MA. (1993).
Variation in the incidence and management of primary breast
cancer in women under 50 years of age (abstract). J. Epidemiol.
Commun. Health. 47, 400.